Five scientists won this year’s Breakthrough Prize in Life Sciences for their work on GLP-1 and the development of drugs for ...

The decision counters a proposal by the Biden Administration to reimburse beneficiaries for the weight-loss medications.

Health and Human Services Secretary Robert F. Kennedy Jr. has been critical of the drugs, instead placing a focus on ...

"We were expecting prices of anti-diabetic medicine Empagliflozin to crash as the medicine went off patent earlier this month. The industry was expecting a price drop by as much as 90%. The same ...

Recent study shows oral semaglutide reduces cardiovascular risk in type 2 diabetes patients, enhancing diabetes and heart ...

CMS said April 4 it will not move forward with a Biden-era proposal to allow Medicare coverage of GLP-1 drugs when prescribed ...

Wockhardt will deepen its novel antibiotics pipeline over the next five years and focus on building a biosimilar business for ...

Linda Bethea details how the marketer of brands including Oikos and Silk is approaching artificial intelligence and emerging ...

More than 7 million people would have gained coverage to the medicine, CMS said when it proposed the rule.